These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29403608)

  • 1. Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia.
    Shaman AA; Mukhtar HB; Mirghani HO
    Electron Physician; 2017 Nov; 9(11):5697-5704. PubMed ID: 29403608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staying up late increases cardiovascular disease risk in women with polycystic ovary syndrome.
    Zeng X; Ye J; Yan X; Zhang J; Guo J; Tao X; Zheng X; Tong M; Huang Y; Zhang M; He C; Chen X; Liu C
    Hum Reprod; 2023 Jul; 38(7):1359-1367. PubMed ID: 37279883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of metabolic syndrome in infertile women with polycystic ovary syndrome in a rural population of South India: A cross-sectional study.
    Kayali S; Chitra T; Kamalanathan S; Nandeesha H
    Int J Reprod Biomed; 2022 Mar; 20(3):161-168. PubMed ID: 35642189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knowledge, Attitude, and Practice of Lifestyle Modifications Among Saudi Women Diagnosed With Polycystic Ovary Syndrome (PCOS).
    Aljuaid A; Sindi HA; Alhadi W; Abu Zayied IA; Althobaiti L; Imran I
    Cureus; 2023 Nov; 15(11):e49398. PubMed ID: 38146573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome.
    Meun C; Gunning MN; Louwers YV; Peters H; Roos-Hesselink J; Roeters van Lennep J; Rueda Ochoa OL; Appelman Y; Lambalk N; Boersma E; Kavousi M; Fauser BC; Laven JS;
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):150-158. PubMed ID: 31638273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic Syndrome and Insulin Resistance Syndrome among Infertile Women with Polycystic Ovary Syndrome: A Cross-Sectional Study from Central Vietnam.
    Le MT; Nguyen VQH; Truong QV; Le DD; Le VNS; Cao NT
    Endocrinol Metab (Seoul); 2018 Dec; 33(4):447-458. PubMed ID: 30513559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiometabolic risk in patients with polycystic ovary syndrome.
    Ozegowska K; Pawelczyk L
    Ginekol Pol; 2015 Nov; 86(11):840-8. PubMed ID: 26817316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome.
    Macut D; Tziomalos K; Božić-Antić I; Bjekić-Macut J; Katsikis I; Papadakis E; Andrić Z; Panidis D
    Hum Reprod; 2016 Jun; 31(6):1347-53. PubMed ID: 27076501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of the triglyceride-glucose index and non-traditional blood lipid parameters in predicting metabolic syndrome in women with polycystic ovary syndrome.
    Zhang L; Wang H; Ma Q; Liu Y; Chen A; Lu J; Ren L
    Hormones (Athens); 2023 Jun; 22(2):263-271. PubMed ID: 36790635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
    Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
    Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
    Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
    J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
    Pourteymour Fard Tabrizi F; Alipoor B; Mehrzad Sadaghiani M; Ostadrahimi A; Malek Mahdavi A
    Int J Fertil Steril; 2013 Jan; 6(4):244-9. PubMed ID: 24520447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome.
    Kałużna M; Czlapka-Matyasik M; Kompf P; Moczko J; Wachowiak-Ochmańska K; Janicki A; Samarzewska K; Ruchała M; Ziemnicka K
    Ther Adv Endocrinol Metab; 2022; 13():20420188211066699. PubMed ID: 35035875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MC4R variants rs12970134 and rs17782313 are associated with obese polycystic ovary syndrome patients in the Western region of Saudi Arabia.
    Batarfi AA; Filimban N; Bajouh OS; Dallol A; Chaudhary AG; Bakhashab S
    BMC Med Genet; 2019 Aug; 20(1):144. PubMed ID: 31429705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'.
    Bhattacharya SM; Jha A
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1303-7. PubMed ID: 21535308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between Serum Vitamin D and Metabolic Syndrome in Women with Polycystic Ovary Syndrome.
    Nandi ER; Fatima P; Deeba F; Ara R; Dey S; Islam F
    Mymensingh Med J; 2023 Jan; 32(1):125-134. PubMed ID: 36594312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women.
    Daghestani MH
    Int J Gynaecol Obstet; 2018 Aug; 142(2):162-169. PubMed ID: 29745981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.